Melatonin enhances the immune response to vaccination against A1 and C strains of Dichelobacter nodosus

Vaccine

Volumn 27, Issue 10, 2009, Pages 1566-1570

  Regodón, Sergio ^a   Ramos, Asunción ^a   Morgado, Sara ^a   Tarazona, Raquel ^a   Martín Palomino, Pedro ^a   Rosado, Juan A ^a   Míguez, María del Prado ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Antibody titer; IgG plasma level; Melatonin

Indexed keywords

BACTERIAL VACCINE; DICHELOBACTER NODOSUS A1 VACCINE; DICHELOBACTER NODOSUS C VACCINE; IMMUNOGLOBULIN G; MELATONIN; MELOVINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CONTROLLED STUDY; DICHELOBACTER NODOSUS; DRUG BLOOD LEVEL; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; DICHELOBACTER NODOSUS; FEMALE; FOOT ROT; GRAM-NEGATIVE BACTERIAL INFECTIONS; IMMUNOGLOBULIN G; MELATONIN; SHEEP; SHEEP DISEASES;

EID: 60349091873     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.001     Document Type: Article

References (30)

1. Levine M.M., and Sztein M.B. Vaccine development strategies for improving immunization: the role of modern immunology. Nat Immunol 5 5 (2004) 460-464
2. Santos W.R., de Lima V.M., de Souza E.P., Bernardo R.R., Palatnik M., and Palatnik de Sousa C.B. Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis. Vaccine 21 1-2 (2002) 30-43
3. McCluskie M.J., and Weeratna R.D. Novel adjuvant systems. Curr Drug Targets Infect Disord 1 3 (2001) 263-271
4. Degen W.G., Jansen T., and Schijns V.E. Vaccine adjuvant technology: from mechanistic concepts to practical applications. Expert Rev Vaccines 2 2 (2003) 327-335
5. Nelson R.J., and Drazen D.L. Melatonin mediates seasonal adjustments in immune function. Reprod Nutr Dev 39 (1999) 383-398
6. Guerrero J.M., and Reiter R.J. Melatonin-immune system relationships. Curr Top Med Chem 2 2 (2002) 167-179
7. Carrillo-Vico A., Calvo J.R., Abreu P., Lardone P.J., García-Mauriño S., Reiter R.J., et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 18 (2004) 537-539
8. Reiter R.J., Melchiorri D., Sewerynek E., Poeggeler B., Barlow-Walden L., and Chuang J. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 18 (1995) 1-11
9. Regodon S, Miguez MP, Jardín I, López JJ, Ramos A, Paredes SD, et al. Melatonin, as an adjuvant-like agent, enhances platelet responsiveness. J Pineal Res; in press.
10. Gonzalez-Haba M., García-Mauriño S., Calvo J., Goberna R., and Guerrero J.M. High-affinity binding of melatonin by human circulating T lymphocytes (CD4+). FASEB J 9 (1995) 1331-1335
11. Maestroni G.J.M. T helper 2 lymphocytes as a peripheral target of melatonin signalling. J Pineal Res 18 (1995) 84-89
12. Regodón S., Martín-Palomino P., Fernández-Montesinos R., Herrera J.L., Carrascosa-Salmoral M.P., Píriz S., et al. The use of melatonin as a vaccine agent. Vaccine 24 (2005) 5321-5327
13. Ben-Nathan D., Maestroni G.J.M., Lustig S., and Conti A. Protective effect of melatonin in mice infected with encephalitis viruses. Arch Virol 140 (1995) 224-230
14. Negrette B., Bonilla E., Valero N., Pons H., García-Tamayo J., Chacín-Bonilla L., et al. Melatonin treatment enhances the efficiency of mice immunization with Venezuelan Equine Encephalomyelitis virus TC-83. Neuroch Res 26 7 (2001) 767-770
15. Egerton J.R., and Parsonson I.M. Isolation of Fusiformis nodosus from cattle. Aust Vet J 42 11 (1966) 425-429
16. Kennan R.M., Dhungyel O.P., Whittington R.J., Egerton J.R., and Rood J.I. The type IV fimbrial subunit gene (fimA) of Dichelobacter nodosus is essential for virulence, protease secretion, and natural competence. J Bacteriol 183 15 (2001) 4451-4458
17. Katz M.E., Howarth P.M., Yong W.K., Riffkin G.G., Depiazzi L.J., and Rood J.I. Identification of three gene regions associated with virulence in Dichelobacter nodosus, the causative agent of ovine footrot. J Gen Microbiol 137 9 (1991) 2117-2124
18. Egerton J.R., Ribeiro L.A., Kieran P.J., and Thorley C.M. Onset and remission of ovine footrot. Aust Vet J 60 11 (1983) 334-336
19. Whittington R.J., and Nicholls P.J. Grading the lesions of ovine footrot. Res Vet Sci 58 1 (1995) 26-34
20. Abbott K.A., and Egerton J.R. Effect of climatic region on the clinical expression of footrot of lesser clinical severity (intermediate footrot) in sheep. Aust Vet J 81 12 (2003) 756-762
21. Abbott K.A., and Lewis C.J. Current approaches to the management of ovine footrot. Vet J 169 1 (2005) 28-41
22. Glynn T. Benign footrot an epidemiological investigation into the occurrence, effects on production, response to treatment and influence of environmental factors. Aust Vet J 70 1 (1993) 7-12
23. Hunt J.D., Jackson D.C., Wood P.R., Stewart D.J., and Brown L.E. Immunological parameters associated with antigenic competition in a multivalent footrot vaccine. Vaccine 13 17 (1995) 1649-1657
24. Hurtado M.A., Píriz S., Valle J., Jiménez R., and Vadillo S. Aetiology of ovine footrot in Spain. Vet Rec 142 3 (1998) 60-63
25. Martín-Palomino P., Píriz S., Jiménez R., Serrano F.J., and Vadillo S. Effectiveness of different adjuvants in stimulating Dichelobacter nodosus antibody in sheep vaccinated against ovine footrot. Acta Vet Hung 52 3 (2004) 275-285
26. Hosie B. Footrot and lameness in sheep. Vet Rec 154 2 (2004) 37-38
27. Viguie C., Caraty A., Locatelli A., and Malpaux B. Regulation of luteinising hormone-releasing hormone (LHRH) secretion by melatonin in the ewe. I. Simultaneous delayed increase in LHRH and luteinising hormone pulsatile secretion. Biol Reprod 52 5 (1995) 1114-1120
28. Malpaux B., Tricoire H., Mailliet F., Daveau A., Migaud M., Skinner D.C., et al. Melatonin and seasonal reproduction: understanding the neuroendocrine mechanisms using the sheep as a model. Reprod Suppl 59 (2002) 167-179
29. Pioli C., Caroleo M.C., Nistico G., and Doria G. Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation. Int J Immunopharmacol 15 4 (1993) 463-468
30. Caroleo M.C., Doria G., and Nistico G. Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. Ann N Y Acad Sci 719 (1994) 343-352